share_log

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4：持股變動聲明-高管 Dogan Meeshanthini
美股SEC公告 ·  2024/09/10 00:10

牛牛AI助理已提取核心訊息

Cardio Diagnostics Holdings, Inc. (CDIO) reported that its Chief Technology Officer, Dogan Meeshanthini, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 197,310 shares. The purchase, conducted on the open market, reflects a vote of confidence in the company's prospects by a key executive.
Cardio Diagnostics Holdings, Inc. (CDIO) reported that its Chief Technology Officer, Dogan Meeshanthini, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 197,310 shares. The purchase, conducted on the open market, reflects a vote of confidence in the company's prospects by a key executive.
Cardio Diagnostics Holdings, Inc. （CDIO） 報告其首席技術官道爾頓·米珊蒂尼（Dogan Meeshanthini）在2024年9月6日購買了公司股票。該交易涉及以每股0.29美元的價格收購了68,965股普通股。在此次交易後，米珊蒂尼在該公司的直接持有股份增加到了總共197,310股。這次在公開市場上進行的購買反映了這位重要高管對公司前景的信心。
Cardio Diagnostics Holdings, Inc. （CDIO） 報告其首席技術官道爾頓·米珊蒂尼（Dogan Meeshanthini）在2024年9月6日購買了公司股票。該交易涉及以每股0.29美元的價格收購了68,965股普通股。在此次交易後，米珊蒂尼在該公司的直接持有股份增加到了總共197,310股。這次在公開市場上進行的購買反映了這位重要高管對公司前景的信心。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間